Back to search

Article

Targeting CHD1L suppresses prostate cancer progression via the FOXO3-PUMA axis

2025-09-03

Abstract excerpt

<title>Abstract</title> <p> Background Prostate cancer (PCa) is one of the most common malignancies in men worldwide, and advanced or metastatic disease remains a major therapeutic challenge. Chromodomain helicase DNA binding protein 1-like (CHD1L) has been implicated as an oncogenic driver in multiple cancer types, yet its role in prostate cancer pathogenesis is not fully defined. The purpose of this study is t...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
e73ee6b6-e1e8-5276-84ad-ac0f12119163
DOI
10.21203/rs.3.rs-7424447/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Targeting CHD1L suppresses prostate cancer progression via the FOXO3-PUMA axisDOI 10.21203/rs.3.rs-7424447/v1
Select a neighboring publication to make it the new centre.